Near‐infrared Activatable Copper Nanoplatforms Synergize with the 5‐Azacytidine Prodrug to Potentiate Cuproptosis

Shuo Wang,Yishen Liu,Mengya Su,Yuanyuan Wang,Wenda Wang,Wuyin Wang,Qichao Yang,Zhiyun Zhang,Xue Hong,Zhijun Sun,Yuling Xiao
DOI: https://doi.org/10.1002/anie.202411609
2024-10-16
Angewandte Chemie International Edition
Abstract:Cuproptosis, a newly discovered cell death modality, is gaining recognition for its crucial role in antitumor therapy. Here, we demonstrated that Ferredoxin 1 (FDX1), a key gene involved in cuproptosis, is negatively correlated with malignancy and T-cell exhaustion in head and neck squamous cell carcinoma (HNSCC). Based on these findings, we developed near-infrared (NIR) light-controlled nanoparticles (NPs), CuD@PM, which can selectively deliver copper to HNSCC cells and induce cuproptosis in the presence of microneedles loaded with triacetylated azacitidine (TAc-AzaC) and 808 nm laser irradiation. Intravenous administration of these NPs significantly suppressed tumor growth in HNSCC animal models and enhanced the antitumor immune response. The NIR-controlled activation of cuproptosis offers great potential as a safe, targeted, and image-guided antitumor therapy for HNSCC.
chemistry, multidisciplinary
What problem does this paper attempt to address?